<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Barrett's multistage process is characterized histopathologically by progression from Barrett's <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> to <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and ultimately <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Understanding the cellular and molecular events in this multistage process may contribute to improved diagnosis and treatment </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="0" ids="18257">Ornithine</z:chebi> decarboxylase (<z:mp ids='MP_0010716'>ODC</z:mp>) is the first enzyme in the biosynthesis of <z:chebi fb="0" ids="51349">polyamines</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Elevated <z:mp ids='MP_0010716'>ODC</z:mp> activity has been found to be associated with progression during <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, but the regulation of <z:mp ids='MP_0010716'>ODC</z:mp> gene expression in the development of Barrett's-associated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> has not been reported </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this study was to assess the prevalence and timing of <z:mp ids='MP_0010716'>ODC</z:mp> <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression in the Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0010716'>ODC</z:mp> <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels, relative to the stably expressed internal reference gene beta-actin, were measured using a quantitative reverse transcription-polymerase chain reaction (RT-PCR) method (ABI 7700 Sequence Detector System) in 104 specimens from 19 patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> without <z:mp ids='MP_0002038'>carcinoma</z:mp> and 22 patients with Barrett's-associated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>The median <z:mp ids='MP_0010716'>ODC</z:mp> <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels were significantly increased in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> tissues compared to matched <z:mpath ids='MPATH_458'>normal</z:mpath> tissues in patients without <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus (P = 0.002; Wilcoxon test) </plain></SENT>
<SENT sid="7" pm="."><plain>A significant progressive increase in <z:mp ids='MP_0010716'>ODC</z:mp> <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was detectable through the stages of the <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence in patients with Barrett's-associated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (r = 0.719; P &lt; or = 0.001; Spearman's rho test) </plain></SENT>
<SENT sid="8" pm="."><plain>These findings show that upregulation of <z:mp ids='MP_0010716'>ODC</z:mp> <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression is an early event in the development and progression of Barrett's-associated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the esophagus, and they suggest that high <z:mp ids='MP_0010716'>ODC</z:mp> <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels may be a clinically useful biomarker for the detection of occult <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>